Structure

Physi-Chem Properties

Molecular Weight:  604.22
Volume:  583.755
LogP:  1.224
LogD:  1.005
LogS:  -3.624
# Rotatable Bonds:  13
TPSA:  193.83
# H-Bond Aceptor:  13
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.14
Synthetic Accessibility Score:  4.659
Fsp3:  0.433
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.803
MDCK Permeability:  7.40760833650711e-06
Pgp-inhibitor:  0.011
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.806
20% Bioavailability (F20%):  0.711
30% Bioavailability (F30%):  0.995

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.065
Plasma Protein Binding (PPB):  92.34600067138672%
Volume Distribution (VD):  0.374
Pgp-substrate:  4.442257881164551%

ADMET: Metabolism

CYP1A2-inhibitor:  0.059
CYP1A2-substrate:  0.065
CYP2C19-inhibitor:  0.037
CYP2C19-substrate:  0.06
CYP2C9-inhibitor:  0.035
CYP2C9-substrate:  0.173
CYP2D6-inhibitor:  0.015
CYP2D6-substrate:  0.102
CYP3A4-inhibitor:  0.431
CYP3A4-substrate:  0.073

ADMET: Excretion

Clearance (CL):  1.112
Half-life (T1/2):  0.744

ADMET: Toxicity

hERG Blockers:  0.277
Human Hepatotoxicity (H-HT):  0.109
Drug-inuced Liver Injury (DILI):  0.578
AMES Toxicity:  0.62
Rat Oral Acute Toxicity:  0.017
Maximum Recommended Daily Dose:  0.002
Skin Sensitization:  0.856
Carcinogencity:  0.25
Eye Corrosion:  0.003
Eye Irritation:  0.05
Respiratory Toxicity:  0.015

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC110063

Natural Product ID:  NPC110063
Common Name*:   Visartiside F
IUPAC Name:   [(3S,4R,5S)-5-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-2-[(E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoxy]-6-(hydroxymethyl)oxan-4-yl]oxy-3,4-dihydroxyoxolan-3-yl]methyl (E)-3-phenylprop-2-enoate
Synonyms:   Visartiside F
Standard InCHIKey:  BBTWTPYIAYLACY-NADHDMBGSA-N
Standard InCHI:  InChI=1S/C30H36O13/c1-38-21-11-9-19(14-20(21)32)8-5-13-39-28-25(35)26(24(34)22(15-31)42-28)43-29-27(36)30(37,17-41-29)16-40-23(33)12-10-18-6-3-2-4-7-18/h2-12,14,22,24-29,31-32,34-37H,13,15-17H2,1H3/b8-5+,12-10+/t22-,24-,25-,26+,27+,28-,29+,30-/m1/s1
SMILES:  COc1ccc(/C=C/CO[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O[C@H]2[C@@H]([C@@](COC(=O)/C=C/c3ccccc3)(CO2)O)O)O)cc1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1077015
PubChem CID:   46184807
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0001766] Fatty acyl glycosides
          • [CHEMONTID:0003861] Fatty acyl glycosides of mono- and disaccharides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. PMID[20121165]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 27800.0 nM PMID[515061]
NPT113 Cell Line RAW264.7 Mus musculus Activity = 85.2 % PMID[515061]
NPT1 Others Radical scavenging activity ED50 > 100.0 uM PMID[515061]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC110063 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9783 High Similarity NPC216819
0.9783 High Similarity NPC287615
0.9783 High Similarity NPC83743
0.9783 High Similarity NPC262182
0.9632 High Similarity NPC226005
0.9577 High Similarity NPC470934
0.9577 High Similarity NPC188393
0.9574 High Similarity NPC192763
0.9574 High Similarity NPC300262
0.9574 High Similarity NPC80732
0.9574 High Similarity NPC215095
0.9574 High Similarity NPC261122
0.9574 High Similarity NPC210611
0.9574 High Similarity NPC28651
0.9574 High Similarity NPC201148
0.9574 High Similarity NPC3460
0.9574 High Similarity NPC199311
0.9565 High Similarity NPC157816
0.9565 High Similarity NPC140502
0.9507 High Similarity NPC90896
0.9507 High Similarity NPC283839
0.95 High Similarity NPC100998
0.95 High Similarity NPC34587
0.95 High Similarity NPC252292
0.95 High Similarity NPC476382
0.95 High Similarity NPC34927
0.9496 High Similarity NPC478239
0.9485 High Similarity NPC157554
0.9433 High Similarity NPC476865
0.9429 High Similarity NPC297342
0.9375 High Similarity NPC143480
0.9375 High Similarity NPC7145
0.9375 High Similarity NPC85192
0.9375 High Similarity NPC125823
0.9366 High Similarity NPC232992
0.9362 High Similarity NPC476864
0.9362 High Similarity NPC476866
0.9362 High Similarity NPC476869
0.9362 High Similarity NPC476868
0.9353 High Similarity NPC186406
0.9348 High Similarity NPC321184
0.9348 High Similarity NPC171134
0.9348 High Similarity NPC100389
0.9348 High Similarity NPC321638
0.9348 High Similarity NPC328273
0.931 High Similarity NPC472611
0.931 High Similarity NPC478268
0.931 High Similarity NPC472612
0.931 High Similarity NPC289967
0.9296 High Similarity NPC199928
0.9291 High Similarity NPC232228
0.9291 High Similarity NPC476867
0.9281 High Similarity NPC202700
0.9265 High Similarity NPC254398
0.9236 High Similarity NPC259347
0.9236 High Similarity NPC106138
0.9236 High Similarity NPC471062
0.9236 High Similarity NPC94871
0.9236 High Similarity NPC476398
0.9236 High Similarity NPC306890
0.9236 High Similarity NPC478242
0.9236 High Similarity NPC476386
0.9236 High Similarity NPC473427
0.9236 High Similarity NPC470933
0.9203 High Similarity NPC37468
0.9203 High Similarity NPC186418
0.9197 High Similarity NPC471883
0.9191 High Similarity NPC252833
0.9191 High Similarity NPC473924
0.9172 High Similarity NPC257970
0.9172 High Similarity NPC470927
0.9167 High Similarity NPC478237
0.9155 High Similarity NPC292443
0.9155 High Similarity NPC196063
0.9155 High Similarity NPC141455
0.9155 High Similarity NPC300894
0.9155 High Similarity NPC296954
0.913 High Similarity NPC476870
0.9128 High Similarity NPC226759
0.9124 High Similarity NPC6836
0.9118 High Similarity NPC219677
0.911 High Similarity NPC269914
0.911 High Similarity NPC478249
0.9085 High Similarity NPC105005
0.9085 High Similarity NPC40305
0.9085 High Similarity NPC46092
0.9078 High Similarity NPC476385
0.9078 High Similarity NPC472711
0.9078 High Similarity NPC134405
0.9071 High Similarity NPC68092
0.9071 High Similarity NPC64141
0.9071 High Similarity NPC81515
0.9071 High Similarity NPC197316
0.9071 High Similarity NPC476383
0.9071 High Similarity NPC472350
0.9071 High Similarity NPC89105
0.9065 High Similarity NPC52277
0.9065 High Similarity NPC199459
0.9065 High Similarity NPC177035
0.906 High Similarity NPC11411
0.9058 High Similarity NPC886
0.9058 High Similarity NPC135127
0.9058 High Similarity NPC34293
0.9058 High Similarity NPC470881
0.9058 High Similarity NPC287597
0.9051 High Similarity NPC473285
0.9041 High Similarity NPC476871
0.9028 High Similarity NPC229505
0.9021 High Similarity NPC129417
0.9021 High Similarity NPC470235
0.9021 High Similarity NPC84181
0.9021 High Similarity NPC283995
0.9014 High Similarity NPC265648
0.9014 High Similarity NPC222433
0.9 High Similarity NPC260425
0.9 High Similarity NPC138738
0.9 High Similarity NPC195196
0.9 High Similarity NPC126206
0.9 High Similarity NPC470413
0.9 High Similarity NPC78363
0.8971 High Similarity NPC477294
0.8971 High Similarity NPC477293
0.8971 High Similarity NPC229784
0.8971 High Similarity NPC307110
0.8958 High Similarity NPC18979
0.8951 High Similarity NPC477898
0.8951 High Similarity NPC470950
0.8951 High Similarity NPC185307
0.8944 High Similarity NPC476377
0.8944 High Similarity NPC47471
0.894 High Similarity NPC478269
0.8936 High Similarity NPC205195
0.8933 High Similarity NPC478266
0.8933 High Similarity NPC228357
0.8929 High Similarity NPC471665
0.8929 High Similarity NPC471664
0.8921 High Similarity NPC35731
0.8919 High Similarity NPC203664
0.8912 High Similarity NPC147224
0.8904 High Similarity NPC308178
0.8897 High Similarity NPC232880
0.8897 High Similarity NPC112861
0.8897 High Similarity NPC225307
0.8882 High Similarity NPC478265
0.8881 High Similarity NPC67467
0.8881 High Similarity NPC476356
0.8873 High Similarity NPC475530
0.8873 High Similarity NPC473799
0.8867 High Similarity NPC38699
0.8865 High Similarity NPC476376
0.8865 High Similarity NPC304152
0.8859 High Similarity NPC89693
0.8859 High Similarity NPC478241
0.8859 High Similarity NPC61604
0.8859 High Similarity NPC299706
0.8859 High Similarity NPC229548
0.8859 High Similarity NPC245615
0.8859 High Similarity NPC115466
0.8859 High Similarity NPC44730
0.8857 High Similarity NPC55040
0.8849 High Similarity NPC25821
0.8844 High Similarity NPC111785
0.8841 High Similarity NPC478255
0.8841 High Similarity NPC248307
0.8841 High Similarity NPC65942
0.8828 High Similarity NPC38041
0.8828 High Similarity NPC279298
0.8828 High Similarity NPC22150
0.8824 High Similarity NPC476873
0.8824 High Similarity NPC149873
0.8824 High Similarity NPC478267
0.8824 High Similarity NPC7191
0.8819 High Similarity NPC247032
0.8819 High Similarity NPC269141
0.8819 High Similarity NPC264632
0.8819 High Similarity NPC96795
0.8819 High Similarity NPC76406
0.8819 High Similarity NPC476381
0.8819 High Similarity NPC476375
0.8819 High Similarity NPC112
0.8819 High Similarity NPC476380
0.8819 High Similarity NPC476378
0.8819 High Similarity NPC175214
0.8819 High Similarity NPC205864
0.8819 High Similarity NPC119537
0.8819 High Similarity NPC476384
0.8819 High Similarity NPC476397
0.8819 High Similarity NPC298257
0.8808 High Similarity NPC163635
0.8808 High Similarity NPC478248
0.8803 High Similarity NPC212770
0.8803 High Similarity NPC98777
0.8803 High Similarity NPC220942
0.88 High Similarity NPC191046
0.88 High Similarity NPC327032
0.88 High Similarity NPC194095
0.8794 High Similarity NPC471988
0.8794 High Similarity NPC470572
0.8786 High Similarity NPC187194
0.8776 High Similarity NPC93924

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC110063 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9071 High Similarity NPD7266 Discontinued
0.8591 High Similarity NPD1653 Approved
0.8333 Intermediate Similarity NPD7685 Pre-registration
0.8086 Intermediate Similarity NPD7228 Approved
0.8079 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8042 Intermediate Similarity NPD3027 Phase 3
0.8 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD6234 Discontinued
0.7975 Intermediate Similarity NPD3818 Discontinued
0.7947 Intermediate Similarity NPD6190 Approved
0.7927 Intermediate Similarity NPD7054 Approved
0.7917 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7899 Intermediate Similarity NPD1357 Approved
0.7898 Intermediate Similarity NPD37 Approved
0.7879 Intermediate Similarity NPD7074 Phase 3
0.7879 Intermediate Similarity NPD7472 Approved
0.7862 Intermediate Similarity NPD4967 Phase 2
0.7862 Intermediate Similarity NPD4965 Approved
0.7862 Intermediate Similarity NPD4966 Approved
0.7755 Intermediate Similarity NPD1613 Approved
0.7755 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD3705 Approved
0.7692 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD7251 Discontinued
0.764 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD7808 Phase 3
0.7619 Intermediate Similarity NPD6797 Phase 2
0.7606 Intermediate Similarity NPD1091 Approved
0.7582 Intermediate Similarity NPD6674 Discontinued
0.7574 Intermediate Similarity NPD6559 Discontinued
0.7574 Intermediate Similarity NPD7240 Approved
0.7561 Intermediate Similarity NPD7199 Phase 2
0.75 Intermediate Similarity NPD5536 Phase 2
0.7485 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD1934 Approved
0.7436 Intermediate Similarity NPD5058 Phase 3
0.7415 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD2977 Approved
0.7407 Intermediate Similarity NPD8455 Phase 2
0.7407 Intermediate Similarity NPD2978 Approved
0.7365 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD6166 Phase 2
0.7321 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7319 Intermediate Similarity NPD228 Approved
0.7317 Intermediate Similarity NPD3882 Suspended
0.7308 Intermediate Similarity NPD4628 Phase 3
0.7301 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD1358 Approved
0.7273 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.726 Intermediate Similarity NPD2983 Phase 2
0.726 Intermediate Similarity NPD2982 Phase 2
0.7256 Intermediate Similarity NPD3817 Phase 2
0.7255 Intermediate Similarity NPD7097 Phase 1
0.7246 Intermediate Similarity NPD8127 Discontinued
0.7238 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7237 Intermediate Similarity NPD230 Phase 1
0.7209 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD7095 Approved
0.7195 Intermediate Similarity NPD2801 Approved
0.7193 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD5844 Phase 1
0.7192 Intermediate Similarity NPD2981 Phase 2
0.7191 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD8313 Approved
0.7184 Intermediate Similarity NPD8312 Approved
0.7181 Intermediate Similarity NPD9494 Approved
0.7181 Intermediate Similarity NPD2861 Phase 2
0.7174 Intermediate Similarity NPD7680 Approved
0.7171 Intermediate Similarity NPD4060 Phase 1
0.7171 Intermediate Similarity NPD3620 Phase 2
0.7171 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD4357 Discontinued
0.7169 Intermediate Similarity NPD7075 Discontinued
0.7143 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD1652 Phase 2
0.7124 Intermediate Similarity NPD1933 Approved
0.7124 Intermediate Similarity NPD4340 Discontinued
0.7117 Intermediate Similarity NPD4380 Phase 2
0.7105 Intermediate Similarity NPD6233 Phase 2
0.7092 Intermediate Similarity NPD5283 Phase 1
0.7091 Intermediate Similarity NPD1465 Phase 2
0.708 Intermediate Similarity NPD3134 Approved
0.7078 Intermediate Similarity NPD2492 Phase 1
0.7078 Intermediate Similarity NPD6653 Approved
0.7067 Intermediate Similarity NPD3018 Phase 2
0.7025 Intermediate Similarity NPD4237 Approved
0.7025 Intermediate Similarity NPD4236 Phase 3
0.7013 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD6355 Discontinued
0.7013 Intermediate Similarity NPD5124 Phase 1
0.7012 Intermediate Similarity NPD7028 Phase 2
0.7006 Intermediate Similarity NPD5763 Approved
0.7006 Intermediate Similarity NPD5762 Approved
0.7 Intermediate Similarity NPD6232 Discontinued
0.6994 Remote Similarity NPD3686 Approved
0.6994 Remote Similarity NPD3687 Approved
0.6988 Remote Similarity NPD5563 Clinical (unspecified phase)
0.6988 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6987 Remote Similarity NPD7033 Discontinued
0.6987 Remote Similarity NPD5588 Approved
0.6986 Remote Similarity NPD5126 Approved
0.6986 Remote Similarity NPD5125 Phase 3
0.6981 Remote Similarity NPD4110 Phase 3
0.6981 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6981 Remote Similarity NPD8166 Discontinued
0.6977 Remote Similarity NPD7473 Discontinued
0.6975 Remote Similarity NPD7314 Clinical (unspecified phase)
0.697 Remote Similarity NPD6386 Approved
0.697 Remote Similarity NPD6385 Approved
0.6964 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6957 Remote Similarity NPD1511 Approved
0.695 Remote Similarity NPD969 Suspended
0.6948 Remote Similarity NPD1558 Phase 1
0.6946 Remote Similarity NPD5402 Approved
0.6943 Remote Similarity NPD2935 Discontinued
0.6939 Remote Similarity NPD3496 Discontinued
0.6936 Remote Similarity NPD3751 Discontinued
0.6932 Remote Similarity NPD7549 Discontinued
0.6928 Remote Similarity NPD3764 Approved
0.6928 Remote Similarity NPD6798 Discontinued
0.6928 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6928 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6927 Remote Similarity NPD6841 Approved
0.6927 Remote Similarity NPD6843 Phase 3
0.6927 Remote Similarity NPD6842 Approved
0.6923 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6923 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6923 Remote Similarity NPD4536 Approved
0.6923 Remote Similarity NPD4538 Approved
0.6918 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6918 Remote Similarity NPD3060 Approved
0.6908 Remote Similarity NPD4908 Phase 1
0.6903 Remote Similarity NPD447 Suspended
0.6901 Remote Similarity NPD7843 Approved
0.6899 Remote Similarity NPD1375 Discontinued
0.6892 Remote Similarity NPD422 Phase 1
0.6886 Remote Similarity NPD7819 Suspended
0.6882 Remote Similarity NPD5494 Approved
0.6875 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7157 Approved
0.6875 Remote Similarity NPD7039 Approved
0.6875 Remote Similarity NPD7038 Approved
0.6871 Remote Similarity NPD1512 Approved
0.6855 Remote Similarity NPD2424 Discontinued
0.6848 Remote Similarity NPD3455 Phase 2
0.6848 Remote Similarity NPD7458 Discontinued
0.6845 Remote Similarity NPD5353 Approved
0.6839 Remote Similarity NPD4140 Approved
0.6829 Remote Similarity NPD5403 Approved
0.6826 Remote Similarity NPD6801 Discontinued
0.6818 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6813 Remote Similarity NPD7421 Clinical (unspecified phase)
0.681 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6809 Remote Similarity NPD3021 Approved
0.6809 Remote Similarity NPD3022 Approved
0.6809 Remote Similarity NPD7435 Discontinued
0.6802 Remote Similarity NPD3787 Discontinued
0.6792 Remote Similarity NPD2029 Clinical (unspecified phase)
0.679 Remote Similarity NPD6783 Clinical (unspecified phase)
0.6786 Remote Similarity NPD5773 Approved
0.6786 Remote Similarity NPD5772 Approved
0.6783 Remote Similarity NPD5535 Approved
0.6779 Remote Similarity NPD1610 Phase 2
0.6778 Remote Similarity NPD8434 Phase 2
0.6774 Remote Similarity NPD4062 Phase 3
0.6772 Remote Similarity NPD4108 Discontinued
0.6772 Remote Similarity NPD5960 Phase 3
0.677 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6765 Remote Similarity NPD5604 Discontinued
0.6759 Remote Similarity NPD6671 Approved
0.6757 Remote Similarity NPD4626 Approved
0.6755 Remote Similarity NPD3225 Approved
0.6748 Remote Similarity NPD5297 Approved
0.6748 Remote Similarity NPD6799 Approved
0.6746 Remote Similarity NPD6374 Clinical (unspecified phase)
0.6738 Remote Similarity NPD2684 Approved
0.6737 Remote Similarity NPD7999 Approved
0.6735 Remote Similarity NPD9545 Approved
0.6735 Remote Similarity NPD1548 Phase 1
0.671 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6708 Remote Similarity NPD5177 Phase 3
0.6707 Remote Similarity NPD3536 Discontinued
0.6707 Remote Similarity NPD4123 Phase 3
0.6707 Remote Similarity NPD5401 Approved
0.6689 Remote Similarity NPD5585 Approved
0.6689 Remote Similarity NPD5691 Approved
0.6688 Remote Similarity NPD5735 Approved
0.6686 Remote Similarity NPD6818 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6273 Approved
0.6667 Remote Similarity NPD6823 Phase 2
0.6667 Remote Similarity NPD7411 Suspended
0.6667 Remote Similarity NPD291 Approved
0.6667 Remote Similarity NPD290 Approved
0.6667 Remote Similarity NPD3750 Approved
0.6649 Remote Similarity NPD6782 Approved
0.6649 Remote Similarity NPD6778 Approved
0.6649 Remote Similarity NPD6777 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data